1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Movember Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors paclitaxel, ifosfamide, cisplatin - Germ Cell Tumor, Teratoma | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 420 | 2015-08-06 | 2026-06-16 |
Choriocarcinoma (1) · Endodermal Sinus Tumor (1) · Germinoma (1) · Neoplasms, Germ Cell and Embryonal (1) · Nonseminomatous germ cell tumor (1) · Seminoma (1) · Teratoma (1)
Carboplatin (1) · Cisplatin (1) · Etoposide (1) · Granulocyte Colony-Stimulating Factor (1) · Ifosfamide (1) · Paclitaxel (1) · etoposide phosphate (1)
Australia (1) · Belgium (1) · Denmark (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
U10CA180821 (1)